The deubiquitinase OTUD3 plays a neuroprotective role by reducing ferroptosis induced by cerebral ischaemia reperfusion via stabilizing PLK1 via deubiquitination

Abstract

Ischaemic stroke is one of the most common serious diseases observed in elderly people, which is caused by ischaemia-reperfusion (I/R) injury. Ovarian tumour domain-containing protein 3 (OTUD3) is a member of the ovarian tumour proteases (OTUs) family of deubiquitination enzymes located in the cytoplasm. We previously showed that the expression of OTUD3 in neurons was significantly reduced after cerebral I/R in mice. In addition, OTUD3 knockdown aggravated ferroptosis and brain damage following I/R in mice, and overexpression of OTUD3 reduced the mortality of cortical neurons in an oxygen glucose deprivation model (OGD/R). Co-immunoprecipitation-mass spectrometry analysis revealed that OTUD3 could bind to the amino acid sequence 35–305 of PLK1. Single-cell sequencing results suggested that PLK1 expression was significantly reduced in mouse neurons after I/R injury. Similarly, reduced PLK1 expression was found in the cortical brain tissues of I/R mice and in the OGD/R-stimulated primary cortical neurons of mice. In vitro experiments showed that OTUD3 overexpression led to the upregulation of PLK1 expression, and inhibition of PLK1 suppressed the inhibitory effect of OTUD3 overexpression on ferroptosis. Moreover, PLK1 positively regulated the PI3K/AKT signalling pathway in neurons after I/R injury, and inhibition of PI3K activity suppressed the inhibitory effect of PLK1 on ferroptosis. Ubiquitination experiments showed that OTUD3 modified PLK1 through deubiquitinating K48-linked ubiquitination, thereby reducing its degradation by ubiquitination and stabilizing PLK1 expression. These results indicated that OTUD3 could upregulate PLK1 through deubiquitination modification, thereby activating the PI3K/AKT signalling pathway and reducing ferroptosis after cerebral I/R. Animal behavioural experiments and cellular methyl thiazolyl tetrazolium and lactate dehydrogenase experiments revealed that inhibition of PLK1 exacerbated brain damage after I/R in mice. Inhibition of OTUD3 deubiquitination enzyme activity attenuated the neuroprotective effect of OTUD3. In conclusion, our findings provide evidence that OTUD3 reduces ferroptosis by upregulating PLK1 expression through deubiquitination modification and exerts neuroprotective effects in cerebral I/R injury.

Keywords

deubiquitination / ischaemia-reperfusion injury / neuroprotection / OTUD3 / PLK1

References

[1] Shahjouei S, Sadighi A, Chaudhary D, et al. A 5-decade analysis of incidence trends of ischemic stroke after transient ischemic attack: a systematic review and meta-analysis. JAMA Neurol. 2021; 78(1): 77-87.

[2] Ekker MS, de Leeuw FE. Higher incidence of ischemic stroke in young women than in young men: mind the gap. Stroke. 2020; 51(11): 3195-3196.

[3] Yeo LL, Paliwal P, Teoh HL, et al. Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke. JAMA Neurol. 2013; 70: 353-358.

[4] Tao T, Liu M, Chen M, et al. Natural medicine in neuroprotection for ischemic stroke: challenges and prospective. Pharmacol Ther. 2020; 216: 107695.

[5] Cheng J, Fan YQ, Jiang HX, et al. Transcranial direct-current stimulation protects against cerebral ischemia-reperfusion injury through regulating cezanne-dependent signaling. Exp Neurol. 2021; 345: 113818.

[6] Hecht N, Schrammel M, Neumann K, et al. Perfusion-dependent cerebral autoregulation impairment in hemispheric stroke. Ann Neurol. 2021; 89(2): 358-368.

[7] Campbell BCV, Khatri P. Stroke. Lancet. 2020; 396(10244): 129-142.

[8] Liu X, Yamashita T, Shang J, et al. Molecular switching from ubiquitin-proteasome to autophagy pathways in mice stroke model. J Cereb Blood Flow Metab. 2020; 40(1): 214-224.

[9] Hochrainer K. Protein modifications with ubiquitin as response to cerebral ischemia-reperfusion injury. Transl Stroke Res. 2018; 9(2): 157-173.

[10] Chen C, Qin H, Tan J, Hu Z, Zeng L. The role of ubiquitin-proteasome pathway and autophagy-lysosome pathway in cerebral ischemia. Oxid Med Cell Longev. 2020; 2020: 5457049.

[11] Liu H, Povysheva N, Rose ME, et al. Role of UCHL1 in axonal injury and functional recovery after cerebral ischemia. Proc Natl Acad Sci U S A. 2019; 116(10): 4643-4650.

[12] Kahles T, Poon C, Qian L, et al. Elevated post-ischemic ubiquitination results from suppression of deubiquitinase activity and not proteasome inhibition. Cell Mol Life Sci. 2021; 78(5): 2169-2183.

[13] Yuan L, Lv Y, Li H, Zhang L. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol. 2015; 17(9): 1169-1181.

[14] Pu Q, Lv YR, Dong K, Geng WW, Gao HD. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells. BMC Cancer. 2020; 20(1): 583.

[15] Du T, Li H, Fan Y, et al. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. Nat Commun. 2019; 10(1): 2914.

[16] Xie P, Chen Y, Zhang H, et al. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma. Aging. 2021; 13(15): 19317-19338.

[17] Hou D, Hu Y, Yun T, Li H, Yang G, Yu D. The deubiquitinase OTUD3 stabilizes IRP2 expression to reduce hippocampal neuron ferroptosis via the p53/PTGS2 pathway to ameliorate cerebral ischemia-reperfusion injury. Eur J Med Res. 2024; 29(1): 498.

[18] Rong Y, Fan J, Ji C, et al. USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 1. Cell Death Differ. 2022; 29(6): 1164-1175.

[19] Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med. 2021; 11(4): e390.

[20] Zhao M, Lu T, Bi G, et al. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis. Biomed Pharmacother. 2023; 168: 115711.

[21] Dixon SJ, Lemberg KM, Lamprecht M, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5): 1060-1072.

[22] García-Yébenes I, Sobrado M, Moraga A. Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion. Neurochem Int. 2012; 61(8): 1364-1369.

[23] Lu LQ, Tian J, Luo XJ, Peng J. Targeting the pathways of regulated necrosis: a potential strategy for alleviation of cardio-cerebrovascular injury. Cell Mol Life Sci. 2021; 78(1): 63-78.

[24] Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1): 84-91.

[25] Wexler EJ, Peters EE, Gonzales A, et al. An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat. J Neurosci Methods. 2002; 113(1): 51-58.

[26] Cheng J, Fan YQ, Liu BH, Zhou H, Wang JM, Chen QX. ACSL4 suppresses glioma cells proliferation via activating ferroptosis. Oncol Rep. 2020; 43(1): 147-158.

[27] Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001; 32(11): 2682-2688.

[28] Clifton GL, Jiang JY, Lyeth BG, Jenkins LW, Hamm RJ, Hayes RL. Marked protection by moderate hypothermia after experimental traumatic brain injury. J Cereb Blood Flow Metab. 1991; 11(1): 114-121.

[29] Sughrue ME, Mocco J, Komotar RJ, et al. An improved test of neurological dysfunction following transient focal cerebral ischemia in rats. J Neurosci Methods. 2006; 151(2): 83-89.

[30] Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013; 4(4): 303-306.

[31] Xu W, Huang Y, Yang Z, et al. Helicobacter pylori promotes gastric epithelial cell survival through the PLK1/PI3K/Akt pathway. Onco Targets Ther. 201811; 11: 5703-5713.

[32] Chen C, Qin H, Tang J, Hu Z, Tan J, Zeng L. USP30 protects against oxygen-glucose deprivation/reperfusion induced mitochondrial fragmentation and ubiquitination and degradation of MFN2. Aging. 2021; 13(4): 6194-6204.

[33] Ganjam GK, Terpolilli NA, Diemert S, et al. Cylindromatosis mediates neuronal cell death in vitro and in vivo. Cell Death Differ. 2018; 25(8): 1394-1407.

[34] Jia F, Li H, Jiao Q, et al. Deubiquitylase OTUD3 prevents Parkinson's disease through stabilizing iron regulatory protein 2. Cell Death Dis. 2022; 13(4): 418.

[35] Zitouni S, Nabais C, Jana SC, Guerrero A, Bettencourt-Dias M. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol. 2014; 15(7): 433-452.

[36] Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S, Niho Y. Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol. 1999; 15(4): 687-692.

[37] Wolf G, Elez R, Doermer A, et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene. 1997; 14(5): 543-549.

[38] Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019; 35(6): 830-849.

[39] Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010; 142(1): 24-38.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.